Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 25
1988 43
1989 62
1990 63
1991 52
1992 53
1993 68
1994 65
1995 61
1996 58
1997 82
1998 81
1999 84
2000 87
2001 100
2002 105
2003 122
2004 130
2005 152
2006 148
2007 194
2008 191
2009 170
2010 205
2011 198
2012 209
2013 191
2014 194
2015 175
2016 185
2017 172
2018 162
2019 122
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

3,619 results
Results by year
Filters applied: . Clear all
Page 1
Vortioxetine: Clinical Pharmacokinetics and Drug Interactions.
Chen G, Højer AM, Areberg J, Nomikos G. Chen G, et al. Clin Pharmacokinet. 2018 Jun;57(6):673-686. doi: 10.1007/s40262-017-0612-7. Clin Pharmacokinet. 2018. PMID: 29189941 Free PMC article. Review.
Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological Disorders.
Cisar JS, Weber OD, Clapper JR, Blankman JL, Henry CL, Simon GM, Alexander JP, Jones TK, Ezekowitz RAB, O'Neill GP, Grice CA. Cisar JS, et al. J Med Chem. 2018 Oct 25;61(20):9062-9084. doi: 10.1021/acs.jmedchem.8b00951. Epub 2018 Aug 23. J Med Chem. 2018. PMID: 30067909
Clinical pharmacokinetics of imatinib.
Peng B, Lloyd P, Schran H. Peng B, et al. Clin Pharmacokinet. 2005;44(9):879-94. doi: 10.2165/00003088-200544090-00001. Clin Pharmacokinet. 2005. PMID: 16122278 Review.
Pharmacogenetics of trazodone in healthy volunteers: association with pharmacokinetics, pharmacodynamics and safety.
Saiz-Rodríguez M, Belmonte C, Derqui-Fernández N, Cabaleiro T, Román M, Ochoa D, Talegón M, Ovejero-Benito MC, Abad-Santos F. Saiz-Rodríguez M, et al. Pharmacogenomics. 2017 Nov;18(16):1491-1502. doi: 10.2217/pgs-2017-0116. Epub 2017 Oct 24. Pharmacogenomics. 2017. PMID: 29061081 Clinical Trial.
Osimertinib Western and Asian clinical pharmacokinetics in patients and healthy volunteers: implications for formulation, dose, and dosing frequency in pivotal clinical studies.
Planchard D, Brown KH, Kim DW, Kim SW, Ohe Y, Felip E, Leese P, Cantarini M, Vishwanathan K, Jänne PA, Ranson M, Dickinson PA. Planchard D, et al. Cancer Chemother Pharmacol. 2016 Apr;77(4):767-76. doi: 10.1007/s00280-016-2992-z. Epub 2016 Feb 22. Cancer Chemother Pharmacol. 2016. PMID: 26902828
An integrated pharmacokinetics ontology and corpus for text mining.
Wu HY, Karnik S, Subhadarshini A, Wang Z, Philips S, Han X, Chiang C, Liu L, Boustani M, Rocha LM, Quinney SK, Flockhart D, Li L. Wu HY, et al. BMC Bioinformatics. 2013 Feb 1;14:35. doi: 10.1186/1471-2105-14-35. BMC Bioinformatics. 2013. PMID: 23374886 Free PMC article.
3,619 results
Jump to page
Feedback